| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Incyte Corp is experiencing significant advancements in product and service development, particularly highlighted by over 50 abstracts to be presented at the ASH Annual Meeting, demonstrating robust innovation within its pipeline. Key themes include the development of targeted therapies and healthcare innovations, both of which aim to address complex diseases effectively. The success of new therapies such as MINJUVI further illustrates the potential for positive patient outcomes. Overall, the company's commitment to innovation positions it strongly in the competitive landscape of healthcare. |
| The price action of Incyte Corp (INCY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.4 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for INCY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.1 on 2025-11-04. The forces of and Valuation Sentiment (-0.8) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.1) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| INCY | |||||||||||||
| Date | Attention | Price | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2025-11-03 | 0%(0%) | 0 | 0% | 0.4 | 3 | -1 | |||||||
| 2025-11-02 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-11-01 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-10-31 | 0%(0%) | 0 | 0% | 0.5 | 3.5 | -1 | |||||||
| 2025-10-30 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-10-29 | 0%(0%) | 0 | 0% | 0.5 | 3.6 | -1 | |||||||
| 2025-10-28 | 0%(0%) | 0 | 0% | 0.5 | 4.1 | 6 | |||||||
| 2025-10-27 | 0%(0%) | 0 | 0% | 1.1 | 4.1 | -1 | |||||||
| 2025-10-26 | 0%(0%) | 0 | 0% | 1.1 | 4.3 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2026-01-11 12:25:28 New targeted therapies are being developed, particularly in the area of mutant selective inhibitors, which may positively impact patient treatment outcomes. |
| 2026-01-11 12:25:28 Biotech stocks are showing improved performance, indicating a potential sustainable rally as market conditions shift favorably. |
| 2026-01-11 12:25:28 Biotech companies are securing significant funding through strategic partnerships and option agreements, enhancing their development capabilities. |
| 2026-01-11 12:25:28 Mergers and acquisitions are becoming more common in the biotech industry, contributing to elevated valuations and investor interest. |
| 2026-01-11 12:25:28 There is a notable recovery in the biotech sector following years of underperformance, driven by successful drug launches and strong trial results. |